Breakthrough Therapies
Multiple breakthrough therapy designations and first-in-class medicines
NYSE · Equity
Johnson & JohnsonJNJ
Johnson & Johnson is a leading multinational healthcare corporation providing pharmaceuticals, medical devices, and consumer products worldwide, with a diversified portfolio spanning innovative medicines, surgical technologies, and trusted consumer brands.
JNJTicker
NYSEExchange
Health CareSector
Price
JNJ chart
NYSE:JNJChart loads on scroll
Profile
Overview
JNJ - Global Healthcare Innovation Leader
Johnson & Johnson (NYSE: JNJ) is a leading multinational healthcare corporation providing pharmaceuticals, medical devices, and consumer products worldwide, with a diversified portfolio spanning innovative medicines, surgical technologies, and trusted consumer brands. Founded in 1886 by Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson and headquartered in New Brunswick, New Jersey, J&J has established itself as one of the world’s most comprehensive healthcare companies with operations in virtually every country globally.
With a commitment to improving human health and well-being, Johnson & Johnson combines cutting-edge research and development with global manufacturing and distribution capabilities to address some of the world’s most pressing health challenges. The company’s focus on innovation, quality, and patient outcomes has created a diversified healthcare platform that serves patients, healthcare professionals, and consumers across the entire spectrum of health and wellness.
Comprehensive Healthcare Portfolio
Johnson & Johnson operates through three primary business segments:
Innovative Medicine (Pharmaceuticals)
Leading pharmaceutical research and development:
- Oncology: Cancer treatments including immunotherapy and targeted therapies
- Immunology: Treatments for autoimmune and inflammatory diseases
- Neuroscience: Therapies for depression, schizophrenia, and neurological disorders
- Cardiovascular & Pulmonary: Heart disease and pulmonary arterial hypertension treatments
- Infectious Diseases: Vaccines and treatments for infectious diseases including HIV and COVID-19
- Rare Diseases: Treatments for rare and orphan diseases
MedTech (Medical Devices)
Comprehensive medical technology and device solutions:
- Surgery: Advanced surgical instruments, robotics, and digital solutions
- Orthopedics: Joint reconstruction, trauma, and spine solutions
- Vision: Contact lenses, intraocular lenses, and vision care products
- Interventional Solutions: Cardiovascular devices and electrophysiology products
- MedTech Portfolio: Comprehensive medical technology across multiple specialties
Consumer Products (Recently Spun Off)
Trusted consumer health and wellness brands:
- Personal Care: Skincare, haircare, and personal hygiene products
- Over-the-Counter: Pain relief, cold/flu, and digestive health products
- Baby Care: Infant and baby care products and safety items
- Wound Care: Adhesive bandages and wound healing products
- Women’s Health: Feminine care and women’s health products
Pharmaceutical Innovation and Drug Development Excellence
Oncology Leadership
Leading cancer immunotherapy and targeted therapy portfolio
Global R&D
Worldwide research and development network and clinical trials
Pipeline Strength
Robust pipeline with dozens of potential blockbuster medicines
Immunology Platform
Leading immunology franchise treating autoimmune diseases
Vaccine Innovation
Innovative vaccine development and global immunization programs
Investment Considerations
Growth Drivers
- Pharmaceutical Innovation: Strong pipeline of innovative medicines across multiple therapeutic areas
- Oncology Leadership: Leading position in cancer immunotherapy and targeted treatments
- Medical Device Innovation: Advanced surgical robotics and minimally invasive technologies
- Emerging Markets: Growth opportunities in developing healthcare markets
- Digital Health: Integration of digital technologies in healthcare delivery
- Biosimilar Protection: Strong patent protection and lifecycle management
Competitive Advantages
- Diversified Portfolio: Balanced portfolio across pharmaceuticals, devices, and consumer products
- Innovation Capabilities: World-class research and development capabilities
- Global Reach: Worldwide presence and healthcare infrastructure
- Brand Recognition: Trusted brands and strong healthcare professional relationships
- Financial Strength: Strong balance sheet and cash generation
- Regulatory Expertise: Deep regulatory knowledge and approval success
Risk Factors
- Patent Expiration: Loss of exclusivity for key pharmaceutical products
- Regulatory Risk: Healthcare regulation and drug approval uncertainties
- Competition: Intense competition from other pharmaceutical and device companies
- Litigation Risk: Product liability and legal challenges
- Healthcare Reform: Healthcare policy changes affecting pricing and reimbursement
- R&D Risk: Clinical trial failures and development setbacks
- Currency Fluctuation: International operations exposure to exchange rate volatility
Pharmaceutical Excellence and Therapeutic Leadership
Oncology Innovation
Leading cancer treatment portfolio and pipeline:
- Darzalex: Multiple myeloma treatment with expanding indications
- Imbruvica: BTK inhibitor for blood cancers and autoimmune diseases
- Erleada: Prostate cancer treatment with strong market position
- Tecvayli: Bispecific antibody for multiple myeloma
- Rybrevant: EGFR-targeted therapy for lung cancer
- CAR-T Therapies: Chimeric antigen receptor T-cell therapies in development
Immunology Platform
Comprehensive autoimmune and inflammatory disease treatments:
- Stelara: IL-12/23 inhibitor for psoriasis, Crohn’s disease, and ulcerative colitis
- Tremfya: IL-23 inhibitor for psoriasis and psoriatic arthritis
- Simponi: TNF inhibitor for rheumatoid arthritis and inflammatory diseases
- Remicade: Established TNF inhibitor with biosimilar competition
- Pipeline Assets: Next-generation immunology treatments in development
Neuroscience and Psychiatry
Mental health and neurological disorder treatments:
- Spravato: Breakthrough nasal spray for treatment-resistant depression
- Concerta: ADHD treatment with long-acting formulation
- Invega: Schizophrenia and schizoaffective disorder treatment
- Alzheimer’s Research: Investment in Alzheimer’s disease research and development
- Depression Pipeline: Novel approaches to depression and mood disorders
Infectious Diseases and Vaccines
Global vaccine development and infectious disease treatments:
- COVID-19 Vaccine: Single-dose COVID-19 vaccine development and distribution
- HIV Prevention: Long-acting HIV prevention and treatment research
- RSV Vaccine: Respiratory syncytial virus vaccine development
- Tuberculosis: TB vaccine research and global health initiatives
- Pandemic Preparedness: Investment in pandemic preparedness and vaccine platforms
Medical Technology and Device Innovation
Surgical Solutions
Advanced surgical instruments and robotic systems:
- Robotic Surgery: Advanced robotic surgical systems and platforms
- Minimally Invasive: Minimally invasive surgical instruments and techniques
- Energy Devices: Advanced energy-based surgical devices
- Sutures and Wound Closure: Comprehensive wound closure and surgical materials
- Digital Surgery: Digital surgical solutions and data analytics
- Training and Education: Surgical training and professional education programs
Orthopedic Excellence
Comprehensive joint reconstruction and orthopedic solutions:
- Hip and Knee: Total joint replacement systems and implants
- Trauma: Trauma implants and fracture repair systems
- Spine: Spinal implants and minimally invasive spine surgery
- Sports Medicine: Sports medicine and arthroscopic surgical products
- Digital Orthopedics: Digital planning and navigation systems
- Regenerative Medicine: Cartilage repair and regenerative orthopedic solutions
Vision Care Leadership
Comprehensive eye care and vision correction products:
- Contact Lenses: Daily disposable and specialty contact lenses
- Intraocular Lenses: Cataract surgery and premium IOL technology
- LASIK: Laser vision correction technology and systems
- Surgical Equipment: Ophthalmic surgical instruments and devices
- Digital Health: Digital eye health monitoring and telehealth solutions
Cardiovascular and Interventional
Advanced cardiovascular devices and interventional solutions:
- Electrophysiology: Cardiac ablation and rhythm management devices
- Structural Heart: Transcatheter valve replacement and repair technologies
- Vascular: Peripheral vascular intervention devices
- Neurovascular: Stroke treatment and neurovascular intervention devices
- Digital Health: Remote monitoring and connected cardiac devices
Consumer Health and Trusted Brands
Personal Care Excellence
Leading consumer personal care and hygiene brands:
- Neutrogena: Premium skincare and dermatologist-recommended products
- Aveeno: Natural skincare and baby care products
- Johnson’s Baby: Trusted baby care and infant hygiene products
- Listerine: Oral care and mouthwash products
- Clean & Clear: Skincare products for teens and young adults
Over-the-Counter Healthcare
Trusted OTC healthcare and pain management:
- Tylenol: Leading acetaminophen pain relief brand
- Motrin: Ibuprofen pain relief and anti-inflammatory products
- Zyrtec: Allergy relief and antihistamine products
- Sudafed: Nasal decongestant and cold/flu products
- Pepcid: Acid reducer and digestive health products
Wound Care and First Aid
Comprehensive wound care and first aid products:
- Band-Aid: Adhesive bandages and wound care products
- Neosporin: Antibiotic ointments and infection prevention
- Advanced Wound Care: Professional wound care and healing products
- Medical Adhesives: Surgical adhesives and medical tapes
Global Research and Development Excellence
Innovation Centers and R&D Network
Worldwide research and development capabilities:
- Janssen R&D: Global pharmaceutical research organization
- Medical Device Innovation: Advanced medical technology research centers
- Digital Health: Digital health and artificial intelligence research
- External Partnerships: Collaboration with academic institutions and biotech companies
- Open Innovation: External collaboration and partnership programs
- Venture Capital: Johnson & Johnson Innovation investment arm
Clinical Development and Regulatory
Comprehensive clinical trial and regulatory capabilities:
- Global Clinical Trials: Worldwide clinical trial network and capabilities
- Regulatory Affairs: Global regulatory strategy and submission expertise
- Real-World Evidence: Real-world data collection and evidence generation
- Pharmacovigilance: Drug safety monitoring and adverse event reporting
- Health Economics: Health economics and outcomes research
- Market Access: Global market access and reimbursement strategies
ESG Leadership and Global Health Impact
Global Health Access
Expanding healthcare access in underserved communities worldwide
Sustainability
Environmental sustainability and carbon neutrality commitments
Health Equity
Addressing health disparities and promoting health equity
Ethical Research
Ethical clinical research and responsible innovation practices
Global Health and Access
Comprehensive programs improving global health outcomes:
- Access Accelerated: Initiative improving access to healthcare in developing countries
- Pandemic Preparedness: Investment in global pandemic preparedness and response
- Maternal Health: Programs improving maternal and child health outcomes
- Infectious Disease: Global initiatives combating tuberculosis, HIV, and malaria
- Non-Communicable Diseases: Programs addressing diabetes, cardiovascular disease, and cancer
- Health Systems Strengthening: Supporting healthcare infrastructure development
Environmental Leadership
Environmental sustainability and climate action:
- Carbon Neutrality: Commitment to carbon neutrality and net-zero emissions
- Sustainable Manufacturing: Environmentally responsible manufacturing processes
- Green Chemistry: Sustainable chemistry and reduced environmental impact
- Packaging: Sustainable packaging and waste reduction initiatives
- Water Stewardship: Responsible water use and conservation programs
- Circular Economy: Circular economy principles and waste minimization
Social Impact and Community Investment
Community development and social responsibility:
- Health Equity: Programs addressing health disparities and social determinants
- STEM Education: Science, technology, engineering, and math education initiatives
- Disaster Relief: Emergency response and disaster relief capabilities
- Employee Volunteering: Employee volunteer programs and community engagement
- Supplier Diversity: Diverse supplier development and inclusion programs
- Human Rights: Commitment to human rights and ethical business practices
Digital Health and Technology Innovation
Digital Therapeutics and Solutions
Digital health technologies and patient solutions:
- Digital Therapeutics: Evidence-based digital interventions for health conditions
- Connected Devices: Internet-connected medical devices and remote monitoring
- Mobile Health: Mobile applications and digital health platforms
- Artificial Intelligence: AI applications for drug discovery and clinical decision support
- Telemedicine: Telehealth solutions and remote patient care
- Data Analytics: Healthcare data analytics and population health management
Precision Medicine and Personalization
Personalized medicine and targeted therapy development:
- Biomarker Development: Companion diagnostics and biomarker identification
- Genomic Medicine: Genetic testing and genomics-based therapeutics
- Pharmacogenomics: Personalized dosing and treatment optimization
- Real-World Evidence: Real-world data for personalized treatment decisions
- Digital Biomarkers: Digital biomarkers and remote patient monitoring
- Predictive Analytics: Predictive modeling for treatment outcomes
Global Operations and Manufacturing Excellence
Manufacturing and Quality
World-class manufacturing and quality systems:
- Global Manufacturing: Manufacturing facilities worldwide ensuring supply security
- Quality Systems: Comprehensive quality assurance and regulatory compliance
- Supply Chain: Global supply chain management and business continuity
- Advanced Manufacturing: Continuous manufacturing and process innovation
- Regulatory Compliance: cGMP compliance and international quality standards
- Sustainability: Sustainable manufacturing and environmental responsibility
Commercial Excellence
Global commercialization and market access:
- Global Commercial: Worldwide commercial operations and market access
- Medical Affairs: Medical affairs and scientific engagement
- Market Access: Reimbursement and health economics support
- Digital Marketing: Digital marketing and healthcare professional engagement
- Patient Support: Patient access programs and adherence support
- Partnerships: Strategic partnerships with healthcare systems and payers
Investment Outlook
Value Proposition
JNJ offers exposure to diversified healthcare with innovation leadership:
- Healthcare Diversification: Balanced exposure across pharmaceuticals, devices, and consumer health
- Innovation Leadership: Leading research and development capabilities across therapeutic areas
- Global Reach: Worldwide presence and healthcare infrastructure
- Defensive Characteristics: Healthcare exposure providing recession resilience
Key Metrics to Monitor
- Pharmaceutical Revenue Growth: Growth in innovative medicine sales and market share
- Pipeline Progress: Clinical trial results and regulatory approval milestones
- Medical Device Performance: MedTech segment growth and market penetration
- R&D Productivity: Research and development efficiency and success rates
- International Expansion: Global market expansion and emerging market growth
- Patent Protection: Intellectual property portfolio and exclusivity periods
- Margin Expansion: Operating leverage and margin improvement trends